{
    "Symbol": "NVS",
    "AssetType": "Common Stock",
    "Name": "Novartis AG ADR",
    "Description": "Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.",
    "CIK": "1114448",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "LICHTSTRASSE 35, BASEL, CH",
    "OfficialSite": "https://www.novartis.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "230518669000",
    "EBITDA": "19296000000",
    "PERatio": "23.33",
    "PEGRatio": "1.73",
    "BookValue": "20.61",
    "DividendPerShare": "3.919",
    "DividendYield": "0.0332",
    "EPS": "4.88",
    "RevenuePerShareTTM": "23.87",
    "ProfitMargin": "0.331",
    "OperatingMarginTTM": "0.334",
    "ReturnOnAssetsTTM": "0.0886",
    "ReturnOnEquityTTM": "0.215",
    "RevenueTTM": "48860000000",
    "GrossProfitTTM": "36744000000",
    "DilutedEPSTTM": "4.88",
    "QuarterlyEarningsGrowthYOY": "0.43",
    "QuarterlyRevenueGrowthYOY": "0.096",
    "AnalystTargetPrice": "117.9",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "3",
    "AnalystRatingHold": "6",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "23.33",
    "ForwardPE": "14.01",
    "PriceToSalesRatioTTM": "4.718",
    "PriceToBookRatio": "5.52",
    "EVToRevenue": "5.14",
    "EVToEBITDA": "13.24",
    "Beta": "0.498",
    "52WeekHigh": "120.92",
    "52WeekLow": "88.8",
    "50DayMovingAverage": "115.28",
    "200DayMovingAverage": "105.52",
    "SharesOutstanding": "2024580000",
    "DividendDate": "2024-04-19",
    "ExDividendDate": "2024-03-07"
}